EN
enGene Holdings Inc. Warrants (ENGNW)
NASDAQ·Healthcare·Biotechnology
$0.27
+7.92%
Mkt Cap $153.59M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$236.90
Range $160.68 – $278.10
Implied Upside
+87705.8%
Consensus $236.90 vs current $0.27